Retour
Fourchette du Jour
207,92 €
212,22 €
Fourchette 52 Semaines
120,72 €
233,60 €
Volume
1 831 772
Moyenne 50J / 200J
217,05 €
/
182,52 €
Clôture Précédente
207,23 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 31,9 | 0,4 |
| P/B | — | 2,9 |
| ROE % | — | 3,9 |
| Net Margin % | 0,7 | 3,8 |
| Rev Growth 5Y % | 8,2 | 10,0 |
| D/E | — | 0,2 |
Objectif de Cours des Analystes
Hold
252,33 €
+19.4%
Low: 220,00 €
High: 275,00 €
P/E Prévisionnel
20,01
BPA Prévisionnel
10,31 €
Croissance BPA (est.)
+0,0%
CA Est.
258,62B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
17,35 €
16,88 € – 17,96 €
|
374,32B | 1 |
| FY2029 |
14,88 €
14,48 € – 15,40 €
|
334,38B | 1 |
| FY2028 |
13,03 €
11,84 € – 14,17 €
|
303,92B | 5 |
No quarterly estimates available
Dividend History
7 yr streakYield
0,01%
Payout Ratio
0,32%
Growth (3Y)
0,90%
Growth (5Y)
0,95%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Apr 01, 2026 | Apr 15, 2026 | 0,51 € | 0,97% |
| Jan 02, 2026 | Jan 15, 2026 | 0,51 € | 0,99% |
| Oct 01, 2025 | Oct 15, 2025 | 0,51 € | 1,29% |
| Jul 01, 2025 | Jul 15, 2025 | 0,51 € | 1,23% |
| Apr 01, 2025 | Apr 15, 2025 | 0,51 € | 1,47% |
| Jan 02, 2025 | Jan 15, 2025 | 0,51 € | 1,71% |
| Oct 01, 2024 | Oct 15, 2024 | 0,51 € | 1,82% |
| Jul 01, 2024 | Jul 15, 2024 | 0,51 € | 2,05% |
| Mar 28, 2024 | Apr 15, 2024 | 0,50 € | 1,79% |
| Dec 29, 2023 | Jan 15, 2024 | 0,50 € | 1,98% |
| Oct 02, 2023 | Oct 15, 2023 | 0,50 € | 2,31% |
| Jun 30, 2023 | Jul 15, 2023 | 0,50 € | 2,10% |
| Mar 31, 2023 | Apr 15, 2023 | 0,50 € | 2,63% |
| Dec 30, 2022 | Jan 15, 2023 | 0,50 € | 2,57% |
| Sep 30, 2022 | Oct 15, 2022 | 0,50 € | 2,96% |
| Jun 30, 2022 | Jul 15, 2022 | 0,50 € | 3,77% |
| Mar 31, 2022 | Apr 15, 2022 | 0,49 € | 3,46% |
| Dec 31, 2021 | Jan 15, 2022 | 0,49 € | 3,80% |
| Sep 30, 2021 | Oct 15, 2021 | 0,49 € | 3,95% |
| Jun 30, 2021 | Jul 15, 2021 | 0,49 € | 3,41% |
Points Clés
Revenue grew 8,19% annually over 5 years — modest growth
Earnings grew 83,22% over the past year
Generating 1,85B in free cash flow
P/E of 31,85 — premium valuation
PEG of 0,30 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 10,06%
Croissance
Revenue Growth (5Y)
8,19%
Revenue (1Y)-1,87%
Earnings (1Y)83,22%
FCF Growth (3Y)-11,52%
Qualité
Return on Equity
N/A
ROIC25,99%
Net Margin0,70%
Op. Margin1,02%
Sécurité
Debt / Equity
N/A
Current Ratio0,94
Interest Coverage10,58
Valorisation
P/E Ratio
31,85
Forward P/E20,01
P/B RatioN/A
EV/EBITDA24,26
Dividend Yield0,01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -1,87% | Revenue Growth (3Y) | 4,20% |
| Earnings Growth (1Y) | 83,22% | Earnings Growth (3Y) | 117,49% |
| Revenue Growth (5Y) | 8,19% | Earnings Growth (5Y) | 26,43% |
| Profitability | |||
| Revenue (TTM) | 222,58B | Net Income (TTM) | 1,56B |
| ROE | N/A | ROA | 2,94% |
| Gross Margin | 3,67% | Operating Margin | 1,02% |
| Net Margin | 0,70% | Free Cash Flow (TTM) | 1,85B |
| ROIC | 25,99% | FCF Growth (3Y) | -11,52% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0,94 |
| Interest Coverage | 10,58 | ||
| Dividends | |||
| Dividend Yield | 0,01% | Payout Ratio | 0,32% |
| Dividend Growth (3Y) | 0,90% | Dividend Growth (5Y) | 0,95% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 31,85 | Forward P/E | 20,01 |
| P/B Ratio | N/A | P/S Ratio | 0,22 |
| PEG Ratio | 0,30 | Forward PEG | N/A |
| EV/EBITDA | 24,26 | Fwd EV/EBITDA | 8,87 |
| Forward P/S | 0,19 | Fwd Earnings Yield | 5,00% |
| FCF Yield | 3,72% | ||
| Market Cap | 49,72B | Enterprise Value | 55,20B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 222,58B | 226,83B | 204,98B | 181,33B | 162,47B |
| Net Income | 1,56B | 852,00M | 330,00M | -938,00M | 611,00M |
| EPS (Diluted) | 6,45 | 3,45 | 1,26 | -3,34 | 2,08 |
| Gross Profit | 8,17B | 7,41B | 6,89B | 6,48B | 6,78B |
| Operating Income | 2,28B | 1,24B | 752,00M | -607,00M | 472,00M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 53,12B | 45,12B | 43,35B | 43,88B | 44,45B |
| Total Liabilities | 55,76B | 48,33B | 46,31B | 44,58B | 42,66B |
| Shareholders' Equity | -2,78B | -3,21B | -2,96B | -709,00M | 1,79B |
| Total Debt | 9,35B | 5,61B | 5,18B | 5,81B | 6,72B |
| Cash & Equivalents | 3,87B | 5,13B | 4,08B | 4,72B | 3,41B |
| Current Assets | 36,37B | 34,88B | 33,74B | 32,94B | 31,05B |
| Current Liabilities | 38,90B | 35,64B | 33,74B | 30,55B | 27,62B |